Core Scientific Gets “It’s Complicated” Status After CoreWeave Deal—Analysts Break Out the Popcorn

by

Quick and Rather Gossipy Rundown:

  • In a stunning plot twist, H.C. Wainwright has gone from fangirl (“buy!”) to “meh” (“neutral”) on Core Scientific, just as CoreWeave swooped in with its all-share offer. (Imagine Bridget Jones’ Diary, but with way less wine and way more server racks.)
  • Apparently, Core Scientific’s fate now clings to CoreWeave’s bumper—so, if CoreWeave sneezes, CoreSci catches a cold. Or possibly pneumonia.
  • Everyone expects shareholders will just sigh and approve the deal, possibly while eating cold pizza.

In the latest episode of “As the Crypto World Turns,” Core Scientific (symbol: CORZ, which may now unofficially stand for “Could Obviously Regret Zigzagging”), has been downgraded from “buy” to “neutral” by the experts at H.C. Wainwright. The culprit? A snuggly new deal with CoreWeave (CRWV), an AI cloud company that’s apparently more complicated than Bridget’s relationship life.

H.C. Wainwright has actually thrown away its price target for Core Scientific, probably in the same way most people throw away their January gym pledges. Why bother? Now, whatever drama happens at CoreWeave will waltz straight over to CoreSci, hand in hand—clingy much?

Markets did the only logical thing: flailed wildly. CoreSci defied gravity with a 1.3% gain at press time (at about $15), but let’s not forget it crashed 18% yesterday, which, even by crypto standards, is a bit much. Meanwhile, CoreWeave slipped 2.6%, possibly from all the excitement.

CoreWeave showed up on Monday with flowers (and a press release), declaring it was buying Core Scientific at an “I swear this is real, based on closing prices” $20.40 per share, all paid in stock. No actual cash—just hope, dreams, and a bit of Excel wizardry.

Optimism? Sure, H.C. Wainwright still sees its own sales forecasts for Core Scientific as “conservative” (code for “if this tanks, don’t blame us”). But they did raise an eyebrow over a number of “unresolved variables.” As in, minor things like: “Do they even have enough servers for this?” and “Where the heck is all the equipment coming from?”

Analysts seem convinced shareholders will sign off on the deal faster than you can say, “Where’s my dividend?” No signs of delays, unless there’s a dramatic reveal or, you know, actual due diligence.

And just to keep it dramatic, H.C. Wainwright gleefully reminds everyone that being in crypto is still basically the business equivalent of BASE jumping without a parachute. Between hashrate whiplash and wild crypto market mood swings, who can sleep at night?

To be fair, Core Scientific does have more irons in the fire than your average bitcoin miner. Unfortunately, the new arrangement means they get a fresh serving of CoreWeave’s unique risks: AI’s actual adoption (spoiler: not just robots making you tea), heavy reliance on a few customers, and enough leverage to make a bank manager sweat.

Other delightful complications include possible shareholder dilution (yay?), mining hardware running on “out of stock” mode, regulatory folks glaring menacingly, and operational mishaps. (Nothing says excitement like a surprise regulatory letter!)

On the “something to tell mum about” side, there’s hope: revenues from high-performance computing (HPC, for those who missed the memo) might arrive to save the day in future quarters, supposedly making CoreSci less twitchy about bitcoin’s moody price cycle 📉. But for now, keep the popcorn handy.

Stay tuned for the next episode—same time, probably different price.

Read More

2025-07-08 17:40